Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.

[1]  M. Kitazawa,et al.  Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation. , 2019, Journal of molecular biology.

[2]  C. Franceschi,et al.  Sex-Specific Associations of Blood-Based Nutrient Profiling With Body Composition in the Elderly , 2019, Front. Physiol..

[3]  Jianrong Xu,et al.  Bis(9)-(−)-Meptazinol, a novel dual-binding AChE inhibitor, rescues cognitive deficits and pathological changes in APP/PS1 transgenic mice , 2018, Translational Neurodegeneration.

[4]  U. Kalinowska-Lis,et al.  Zinc‐containing compounds for personal care applications , 2018, International journal of cosmetic science.

[5]  N. Kokras,et al.  Acetyl Cholinesterase Inhibitors and Cell-Derived Peripheral Inflammatory Cytokines in Early Stages of Alzheimer's Disease , 2018, Journal of clinical psychopharmacology.

[6]  G. Pawelec,et al.  Role of the peripheral innate immune system in the development of Alzheimer's disease , 2017, Experimental Gerontology.

[7]  R. Stewart,et al.  Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis , 2018, Age and ageing.

[8]  Zhan-You Wang,et al.  Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies , 2017, Front. Aging Neurosci..

[9]  A. Bush,et al.  Extracellular Zn2+ Is Essential for Amyloid β1–42-Induced Cognitive Decline in the Normal Brain and Its Rescue , 2017, The Journal of Neuroscience.

[10]  H. Uzun,et al.  The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  P. Sachdev,et al.  Identification of Cerebral Metal Ion Imbalance in the Brain of Aging Octodon degus , 2017, Front. Aging Neurosci..

[12]  M. Provinciali,et al.  Main biomarkers associated with age-related plasma zinc decrease and copper/zinc ratio in healthy elderly from ZincAge study , 2017, European Journal of Nutrition.

[13]  Y. Kakinuma,et al.  Donepezil, an acetylcholinesterase inhibitor, attenuates LPS-induced inflammatory response in murine macrophage cell line RAW 264.7 through inhibition of nuclear factor kappa B translocation. , 2016, European journal of pharmacology.

[14]  M. Kitazawa,et al.  Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  C. Gagliardi,et al.  My Mind Project: the effects of cognitive training for elderly—the study protocol of a prospective randomized intervention study , 2016, Aging Clinical and Experimental Research.

[16]  C. Gomes,et al.  Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease , 2016, Oxidative medicine and cellular longevity.

[17]  Miki Suzuki,et al.  Excess influx of Zn2+ into dentate granule cells affects object recognition memory via attenuated LTP , 2015, Neurochemistry International.

[18]  E. Ho,et al.  Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation. , 2015, Molecular nutrition & food research.

[19]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[20]  C. Cunningham,et al.  Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research , 2015, Alzheimer's Research & Therapy.

[21]  Jia Sun,et al.  Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses. , 2015, Journal of Alzheimer's disease : JAD.

[22]  I. Simonelli,et al.  Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies. , 2015, Journal of Alzheimer's disease : JAD.

[23]  J. Gómez-Ariza,et al.  Homeostasis of metals in the progression of Alzheimer’s disease , 2014, BioMetals.

[24]  P. Mecocci,et al.  Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 , 2014, Journal of internal medicine.

[25]  E. Gonos,et al.  Micronutrient–gene interactions related to inflammatory/immune response and antioxidant activity in ageing and inflammation. A systematic review , 2014, Mechanisms of Ageing and Development.

[26]  M. Oh,et al.  Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo. , 2014, Neurotoxicology.

[27]  J. Molinuevo,et al.  Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease , 2013, American journal of Alzheimer's disease and other dementias.

[28]  R. Galeazzi,et al.  Comparison of intracellular zinc signals in nonadherent lymphocytes from young-adult and elderly donors: role of zinc transporters (Zip family) and proinflammatory cytokines. , 2012, The Journal of nutritional biochemistry.

[29]  L. Rink,et al.  Repletion of zinc in zinc-deficient cells strongly up-regulates IL-1β-induced IL-2 production in T-cells. , 2012, Metallomics : integrated biometal science.

[30]  G. Pawelec,et al.  Immune profiling of Alzheimer patients , 2012, Journal of Neuroimmunology.

[31]  Jan Hellemans,et al.  Zinc transporter mRNA levels in Alzheimer's disease postmortem brain. , 2012, Journal of Alzheimer's disease : JAD.

[32]  P. Pasqualetti,et al.  Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies. , 2011, Journal of Alzheimer's disease : JAD.

[33]  F. Lattanzio,et al.  Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population , 2010, Biogerontology.

[34]  B. Hu,et al.  Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway , 2009, Brain, Behavior, and Immunity.

[35]  V. Pavlov,et al.  Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway , 2009, Brain, Behavior, and Immunity.

[36]  P. Pasqualetti,et al.  Longitudinal prognostic value of serum “free” copper in patients with Alzheimer disease , 2009, Neurology.

[37]  I. Shmulevich,et al.  Age-dependent signature of metallothionein expression in primary CD4 T cell responses is due to sustained zinc signaling. , 2008, Rejuvenation research.

[38]  M. Malavolta,et al.  Zinc–gene interaction related to inflammatory/immune response in ageing , 2008, Genes & Nutrition.

[39]  R. Hansen,et al.  Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis , 2008, Clinical interventions in aging.

[40]  D. Salt,et al.  Slc39a1 to 3 (subfamily II) Zip genes in mice have unique cell-specific functions during adaptation to zinc deficiency. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[41]  E. Barrett-Connor,et al.  Plasma trace elements and cognitive function in older men and women: The Rancho Bernardo study , 2008, The journal of nutrition, health & aging.

[42]  C. Caruso,et al.  Zinc and Inflammatory/Immune Response in Aging , 2007, Annals of the New York Academy of Sciences.

[43]  K. Tracey Physiology and immunology of the cholinergic antiinflammatory pathway. , 2007, The Journal of clinical investigation.

[44]  A. Albores,et al.  Early effects of surgery on zinc and metallothionein levels in female rats , 1999, Biological Trace Element Research.

[45]  Lothar Rink,et al.  Correlation between zinc status and immune function in the elderly , 2006, Biogerontology.

[46]  T. Ganz,et al.  Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Gambi,et al.  Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1β and interleukin-6 release from lymphocytes of Alzheimer's disease patients , 2005, Experimental Gerontology.

[48]  W. Maret,et al.  Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. , 2005, Journal of Alzheimer's disease : JAD.

[49]  J. Marcusson,et al.  Rivastigmine as a Modulator of the Neuronal Glutamate Transporter rEAAC1 mRNA Expression , 2004, Dementia and Geriatric Cognitive Disorders.

[50]  R. Uzzo,et al.  Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes , 2001, Apoptosis.

[51]  A. Akaike,et al.  Nicotinic Acetylcholine Receptor-Mediated Neuroprotection by Donepezil Against Glutamate Neurotoxicity in Rat Cortical Neurons , 2003, Journal of Pharmacology and Experimental Therapeutics.

[52]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[53]  M. Molaschi,et al.  Determination of selected trace elements in patients affected by dementia. , 1996, Archives of gerontology and geriatrics.

[54]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[55]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[56]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[57]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[58]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.